Clinical trial
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse…
NCT00235053 · Allergy & Asthma Medical Group & Research Center, Other · Completed
Key facts
| NCT number | NCT00235053 |
|---|---|
| Title | Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID |
| Official title | A Pilot Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID as Assessed by the Development of Laryngitis and Oropharyngeal Candidiasis in Adults With Mild Persistent Asthma |
| Lead sponsor | Allergy & Asthma Medical Group & Research Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, Candidiasis, Oral, Voice Disorders |
| Intervention type | Drug |
| Interventions | fluticasone/salmeterol DISKUS 250/50 |
| Enrollment | 13 |
| Start date | Aug 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 10, 2005 |
| Last update posted | Jan 30, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: